Sponsored Podcasts
Advertisement
Advertisement
In this interview, we will talk about the typical developmental process of new vaccines and how the current Covid-19 situation influences the global vaccine developmental landscape.
Advertisement
The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada.
Advertisement
Advertisement
Trending on BioPharm International
1
GSK’s Arexvy Gains EU Approval for Adults Aged 18 Years and Older
2
New $82 Million Biopharma Launch Targets Rare Disease Development With AI-Driven Strategy
3
WHO Finalizes United States’ Withdrawal from Organization: Report
4
Bio/pharma Manufacturing Professionals Are Staying Put Despite Growing Uncertainty
5